Latest filing published 14 Nov 2019 for GENOMIC HEALTH INC.
Laura Leber is a declared insider of Genomic Health Inc, with filings sourced from SEC (Form 4). We count 31 filings; the first trade dates from 15 February 2016 and the latest from 8 November 2019.
Sales make up the whole of the open-market record (13 sales, €3.6M). Other entries cover 8 share grants and 6 option exercises. Since January 2019: no purchases and 6 sales on the market.
The newest entry dates from 14 November 2019: a transaction, in Genomic Health Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations